FDA has granted NTX-001 fast-track eligibility: to treat peripheral nerve damage (PNI)
-
Last Update: 2020-05-30
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Neuraptive, a clinical-stage biotech company dedicated to developing new treatments for peripheral nerve damage (PNI), announced today that the U.SFood and Drug Administration (FDA) has granted NTX-001 fast-track eligibility to treat peripheral nerve damage (PNI)The FDA Fast Track Program aims to promote and accelerate the development and review of new drugs with a view to providing patients with more effective new therapies earlier"We are pleased that the FDA is aware of the urgent need for new treatments to improve nerve damage," said Evan Tzanis, executive vice president and head of research and development at NeuraptiveSince there are currently no products available to help quickly restore nerve function, NTX-001 may make significant improvements to current care standardsFast Pass eligibility can speed up the launch of the NTX-001." The FDA approved the company's research new drug application (IND) for NTX-001 in AprilPNI is mainly characterized by movement and sensory disorders in the neural root distribution areaThe upper arm damage is characterized by the drooping of the upper limb, the upper arm, and a narrow sensory barrier area on the outside of the shoulder blade, upper arm and forearm
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
